Abstract:Emily OC Palmer, 1 Sheryl Ker, 2 Miguel E Rentería, 3 Thomas Carmody, 4 A John Rush 5, 6 1 Holmusk Europe Ltd, London, UK; 2 KKT Technologies, Pte. Ltd, Singapore; 3 QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; 4 Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA; 5 Duke University School of Medicine, Duke University School of Medicine, Durham, NC, USA; 6 Clinical sciences, Duke-National University of Singapore, Singapore Correspondence: Emily OC Palmer, Holmusk Europe Ltd, 414 Linen Hall, 162-168 Regent St, London, W1B 5TE, UK, Email Purpose: Major depressive disorder (MDD) is a leading cause of disability worldwide. An accurate assessment of depressive symptomology is crucial for clinical management and research. This study assessed the convergent validity, reliability, and total scale score interconversion across the 9-item Patient Health Questionnaire (PHQ-9) self-report, the 16-item Quick Inventory of Depressive Symptomatology-clinician report (QIDS-C) (two widely used clinical ratings) and the 5-item Very Brief Quick Inventory of Depressive Symptoms-clinician report (VQIDS-C), which evaluate the core features of MDD. Patients and Methods: This study leveraged electronic health record (EHR)-derived, de-identified data from the NeuroBlu Database (Version 23R1), a longitudinal behavioural health real-world platform. Classical Test Theory (CTT) and Item Response Theory (IRT) analyses were used to evaluate the reliability, validity of, and conversions between the scales. The Test Information Function (TIF) was calculated for each scale, with greater test information reflecting higher precision and reliability in measuring depressive symptomology. IRT was also used to generate conversion tables so that total scores on each scale could be compared to the other. Results: The study sample (n = 2,156) had an average age of 36.4 years (standard deviation [SD] = 13.0) and 59.7% were female. The mean depression scores for the PHQ-9, QIDS-C, and VQIDS-C were 12.9 (SD = 6.6), 12.0 (SD = 4.9), and 6.18 (SD = 3.2), respectively. The Cronbach's alpha coefficients for PHQ-9, QIDS-C, and VQIDS-C were 0.9, 0.8, and 0.7, respectively, suggesting acceptable internal consistency. PHQ-9 (TIF = 30.3) demonstrated the best assessment of depressive symptomology, followed by QIDS-C (TIF = 25.8) and VQIDS-C (TIF = 17.7). Conclusion: Overall, PHQ-9, QIDS-C, and VQIDS-C appear to be reliable and convertible measures of MDD symptomology within a US-based adult population in a real-world clinical setting. Keywords: psychometrics, linking, patient health questionnaire, quick inventory of depressive symptoms, depression, real-world data Major depressive disorder (MDD) is a leading cause of disability worldwide, with an estimated lifetime prevalence in the United States (US) of 20%. 1 Accurate and reliable assessment of MDD is crucial for effective treatment and management. The Patient Health Questionnaire-9 (PHQ-9; self-report) and the clinician rated Quick Inventory of Depressive Symptomatology (QIDS-C) 2 are widely used and validated tools to assess the prevalence and severity of depressive symptoms in patients with MDD. These scales are used both in clinical research and practice. The PHQ-9 assesses the prevalence over the past two weeks of the nine criterion depressive symptom domains that define a major depressive episode based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 3 It is a self-administered questionnaire that can be completed in a few minutes, making it a convenient tool for clinicians and patients. The PHQ-9 has demonstrated good psychometric properties in various populations, including adults 4,5 and adolescents, 6 and has been translated into multiple languages. 7–13 The QIDS-C consists of 16 items that cover the same nine DSM-5 criterion symptom domains; it has clinician report and self-report versions. 2,14 The QIDS-C has demonstrated good psychometric properties, including high internal consistency, test-retest reliability, and strong convergent validity with other depression measures. 15 In recent years, the 5-item Very Quick Inventory of Depressive Symptomatology (VQIDS-C) 16 was developed as a more convenient method for rapid clinical assessment and is effective at evaluating the core features of depression. The self-report version of the QIDS and PHQ-9 have been compared in Asian primary care settings and shown good internal consistency. 17 However, these measures have not been evaluated together in a lar -Abstract Truncated-

Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trial

Validation of the Nine-Item Patient Health Questionnaire to Screen for Major Depression in A Chinese Primary Care Population

Reliability and Validity of the Phq-9 for Screening Late-Life Depression in Chinese Primary Care

The Accuracy of the Patient Health Questionnaire-9 Algorithm for Screening to Detect Major Depression: An Individual Participant Data Meta-Analysis

The Patient Health Questionnaire-9 vs. the Hamilton Rating Scale for Depression in Assessing Major Depressive Disorder

The Reliability and Validity of the Patient Health Questionnaire Depression Scale(PHQ-9)in the Elderly Population in Community

Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis

Equating the PHQ-9 and GAD-7 to the HADS depression and anxiety subscales in patients with major depressive disorder

Development and validation of the Maudsley Modified Patient Health Questionnaire (MM-PHQ-9)

Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis

Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies

External validation of a shortened screening tool using individual participant data meta-analysis: A case study of the Patient Health Questionnaire-Dep-4

Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorder

Patient Health Questionnaire-9: A clinimetric analysis

Validation of Patient Health Questionnaire (PHQ) for Major Depression in Chinese Outpatients with Multiple Somatic Symptoms: a Multicenter Cross-Sectional Study.

Measurement invariance of the patient health questionnaire‐9 (PHQ‐9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005–2016

Responsiveness of PROMIS and Patient Health Questionnaire (PHQ) Depression Scales in three clinical trials

An exploratory graphical analysis of the Montgomery-Åsberg Depression Rating Scale pre- and post-treatment using pooled antidepressant trial secondary data

A qualitative investigation of the Montgomery–Åsberg depression rating scale: discrepancies in rater perceptions and data trends in remote assessments of rapid-acting antidepressants in treatment resistant depression

Machine learning algorithm-based estimation model for the severity of depression assessed using Montgomery-Asberg depression rating scale